Avance IVDR

标准化的核磁共振（NMR）光谱平台可实现成本效益，高性能NMR临床前筛选和IVD-by-NMR发现和验证（在RUO级别）的新型NMR分析。新的Avance IVDR系统目前仅用于研究使用，是NMR临床前研究和筛查以及IVD-by-NMR研究的完整，经过验证和标准化的平台。

It features high sensitivity and information-rich output at 600 MHz proton-NMR frequency, and incorporates advanced hardware, software, automation, spectral libraries and standard operating procedures (SOPs) for high-performance biofluid assay validation and pre-clinical screening. Customer benefits include higher information content and spectral feature differentiation compared to low-field NMR systems, as well as excellent reproducibility, high throughput and potentially dramatically lower cost per sample for better preparation and support of clinical screening and IVD-by-NMR discovery and validation (on RUO level).

• 最小的样本preparationn
• Non-destructive measurement
• 在高吞吐量筛选模式下完全自动化
• Highest reproducibility and data quality from sample to sample and instrument to instrument
• Quantification of large sets of metabolites with automated reporting
  Classification and discriminiation using statistical tools with automated reporting
• Low cost per sample and lowest cost per parameter, with small footprint to suit every lab

• 无需复杂的样品准备或样品识别
• 易用性 - 不需要NMR的操作员专业知识
  
• Highest reproducibility and data quality under full automation – anytime & anywhere
  
• Handling of large data sets with simple retrieval of information
  
• Rapid transfer from spectra to relevant information
  
• 回顾性分析
  
• Integration of spectra and results from different groups world wide

High Performance and Throughput IVD-by-NMR Research

Paving the way for worldwide epidemiological studies as well as for preclinical research.

Avance IVDR专用于基于NMR的临床前体外筛查和研究，以易用和最高的数据质量，可靠性和可重复性优化，如右侧图所示。新的标准化平台提供条形码分析，通过LIMS系统控制，高通量AutoSampler SampleJet™，远程访问以及自动分析以及可自定义的分析结果报告。

Based on Bruker-validated SOPs, the AVANCE IVDr platform enables the development of future potential diagnostic tools for body-fluids that can address a variety of medical questions. The SOPs guarantee the preparation of highly reproducible clinical data, enabling the exchange and validation of novel NMR assays between laboratories on a global basis. In a translational clinical research environment the results produced by these NMR assays can easily be transferred into potential clinical screening and future IVD use.

This level of large-scale health-related NMR screening is paving the way for worldwide epidemiological studies as well as for pre-clinical in vitro research. The benefits have been significant: facilitated by the low cost per sample and the even lower cost per parameter as compared to established single parameter screening methods.

确定疾病原因，提供个性化患者治疗的新型NMR方法现在使许多临床研究人员能够制定预防策略。